<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">32314898</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>28</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2618-0456</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>38</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Apr</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology</Title>
          <ISOAbbreviation>Hua Xi Kou Qiang Yi Xue Za Zhi</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Research progress on the expression and function of erythropoietin-producing hepatomocellular receptors and their receptor-interacting proteins in oral-related diseases].</ArticleTitle>
        <Pagination>
          <StartPage>218</StartPage>
          <EndPage>223</EndPage>
          <MedlinePgn>218-223</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.7518/hxkq.2020.02.018</ELocationID>
        <Abstract>
          <AbstractText>Erythropoietin-producing hepatomocellular receptors and their receptor-interacting proteins (Eph/ephrin) can participate in the regulation of growth and development and promote the development of diseases through short-distance signal transduction between cells. To study the mechanism of Eph/ephrin and oral-related diseases, we provided a new theoretical basis and a strategy for the treatment of oral diseases. The Eph/ephrin pathway has been used to regulate oral diseases, especially in periodontal disease prevention, orthodontic bone reconstruction, and biological treatment of oral tumors. This paper reviews the research progress of Eph/ephrin pathway in oral-related diseases.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Qi</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Dept. of Stomatology, North Sichuan Medical College, Nanchong 637000, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Yan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Dept. of Prosthodontics, the Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Yun</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Dept. of Stomatology, North Sichuan Medical College, Nanchong 637000, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Li-Zhong</ForeName>
            <Initials>LZ</Initials>
            <AffiliationInfo>
              <Affiliation>Dept. of Stomatology, North Sichuan Medical College, Nanchong 637000, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Lin-Xuan</ForeName>
            <Initials>LX</Initials>
            <AffiliationInfo>
              <Affiliation>Dept. of Stomatology, North Sichuan Medical College, Nanchong 637000, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Han</LastName>
            <ForeName>Mei</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Dept. of Stomatology, North Sichuan Medical College, Nanchong 637000, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mi</LastName>
            <ForeName>Fang-Lin</ForeName>
            <Initials>FL</Initials>
            <AffiliationInfo>
              <Affiliation>Dept. of Stomatology, North Sichuan Medical College, Nanchong 637000, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>chi</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Hua Xi Kou Qiang Yi Xue Za Zhi</MedlineTA>
        <NlmUniqueID>9422648</NlmUniqueID>
        <ISSNLinking>1000-1182</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D036342">Ephrins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>11096-26-7</RegistryNumber>
          <NameOfSubstance UI="D004921">Erythropoietin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.10.1</RegistryNumber>
          <NameOfSubstance UI="D036081">Receptors, Eph Family</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D036342" MajorTopicYN="N">Ephrins</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004921" MajorTopicYN="Y">Erythropoietin</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036081" MajorTopicYN="Y">Receptors, Eph Family</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <OtherAbstract Type="Publisher" Language="chi">
        <AbstractText>促红细胞生成素肝细胞激酶受体及其膜结合配体（Eph/ephrin）可以通过细胞与细胞间短距离的信号传导，参与调节生长发育，促进疾病发生发展的各个过程。研究Eph/ephrin与口腔相关疾病的机制可以为口腔疾病的治疗提供新的思路。近年来，针对Eph/ephrin通路调控口腔相关疾病，尤其是在牙周疾病防治、正畸骨改建以及口腔肿瘤的生物学治疗领域的研究逐渐深入，本文即对这3个方面的研究进展进行综述。.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">erythropoietin-producing hepatomocellular receptors and their receptor-interacting proteins</Keyword>
        <Keyword MajorTopicYN="N">orthodontics</Keyword>
        <Keyword MajorTopicYN="N">periodontitis</Keyword>
        <Keyword MajorTopicYN="N">tumor</Keyword>
      </KeywordList>
      <CoiStatement>利益冲突声明：作者声明本文无利益冲突。</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32314898</ArticleId>
        <ArticleId IdType="pmc">PMC7184288</ArticleId>
        <ArticleId IdType="doi">10.7518/hxkq.2020.02.018</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Matsuo K, Otaki N. Bone cell interactions through Eph/ephrin: bone modeling, remodeling and associated diseases[J] Cell Adh Migr. 2012;6(2):148–156.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3499314</ArticleId>
            <ArticleId IdType="pubmed">22660185</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>吴 梓齐, 杨 涛源, 王 景云. 浅谈EphrinB2/ephB4在骨重建中的作用[J] 中华老年口腔医学杂志. 2014;12(3):184–187.</Citation>
        </Reference>
        <Reference>
          <Citation>Wu ZQ, Yang TY, Wang JY. The role of EphrinB2/ephB4 in bone reconstruction[J] Chin J Geriatric Dent. 2014;12(3):184–187.</Citation>
        </Reference>
        <Reference>
          <Citation>赵 鹃, 毛 英杰, 谷 志远. 骨吸收与骨形成耦联中Eph/ephrin信号转导的研究进展[J] 生物化学与生物物理进展. 2009;36(9):1101–1105.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhao J, Mao YJ, Gu ZY. Progress in researches of Eph/ephrin signaling in coupling of bone resorption and bone formation[J] Prog Bioche Biophy. 2009;36(9):1101–1105.</Citation>
        </Reference>
        <Reference>
          <Citation>Ji YJ, Hwang YS, Mood K, et al.  EphrinB2 affects apical constriction in Xenopus embryos and is regulated by ADAM10 and flotillin-1[J] Nat Commun. 2014(5):3516.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4120273</ArticleId>
            <ArticleId IdType="pubmed">24662724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arvanitis DN, Béhar A, Tryoen-Tóth P, et al.  Ephrin B1 maintains apical adhesion of neural progenitors[J] Development. 2013;140(10):2082–2092.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23578932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rakic P. Specification of cerebral cortical areas[J] Science. 1988;241(4862):170–176.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3291116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bouché E, Romero-Ortega MI, Henkemeyer M, et al.  Reelin induces EphB activation[J] Cell Res. 2013;23(4):473–490.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3616423</ArticleId>
            <ArticleId IdType="pubmed">23318582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dimidschstein J, Passante L, Dufour A, et al.  Ephrin-B1 controls the columnar distribution of cortical pyramidal neurons by restricting their tangential migration[J] Neuron. 2013;79(6):1123–1135.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24050402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>García-Frigola C, Carreres MI, Vegar C, et al.  Zic2 promotes axonal divergence at the optic chiasm midline by EphB1-dependent and -independent mechanisms[J] Development. 2008;135(10):1833–1841.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18417618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adams RH, Wilkinson GA, Weiss C, et al.  Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis[J] Genes Dev. 1999;13(3):295–306.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC316426</ArticleId>
            <ArticleId IdType="pubmed">9990854</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang HU, Chen ZF, Anderson DJ. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4[J] Cell. 1998;93(5):741–753.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9630219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindskog H, Kim YH, Jelin EB, et al.  Molecular identification of venous progenitors in the dorsal aorta reveals an aortic origin for the cardinal vein in mammals[J] Development. 2014;141(5):1120–1128.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3929407</ArticleId>
            <ArticleId IdType="pubmed">24550118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakayama M, Nakayama A, van Lessen M, et al.  Spatial regulation of VEGF receptor endocytosis in angiogenesis[J] Nat Cell Biol. 2013;15(3):249–260.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3901019</ArticleId>
            <ArticleId IdType="pubmed">23354168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sawamiphak S, Seidel S, Essmann CL, et al.  Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis[J] Nature. 2010;465(7297):487–491.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20445540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liao C, Cheng T, Wang S, et al.  Shear stress inhibits IL-17A-mediated induction of osteoclastogenesis via osteocyte pathways[J] Bone. 2017;101:10–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28414140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie H, Cui Z, Wang L, et al.  PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis[J] Nat Med. 2014;20(11):1270–1278.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4224644</ArticleId>
            <ArticleId IdType="pubmed">25282358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao C, Irie N, Takada Y, et al.  Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis[J] Cell Metab. 2006;4(2):111–121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16890539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuo K, Irie N. Osteoclast-osteoblast communication[J] Arch Biochem Biophys. 2008;473(2):201–209.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18406338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tonna S, Takyar FM, Vrahnas C, et al.  EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis[J] FASEB J. 2014;28(10):4482–4496.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24982128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Irie N, Takada Y, Watanabe Y, et al.  Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis[J] J Biol Chem. 2009;284(21):14637–14644.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2682911</ArticleId>
            <ArticleId IdType="pubmed">19299512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun W, Zhao C, Li Y, et al.  Osteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activity[J] Cell Discov. 2016;2:16015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4886818</ArticleId>
            <ArticleId IdType="pubmed">27462462</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kwan Tat S, Pelletier JP, Amiable N, et al.  Treatment with ephrin B2 positively impacts the abnormal metabolism of human osteoarthritic chondrocytes[J] Arthritis Res Ther. 2009;11(4):R119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2745802</ArticleId>
            <ArticleId IdType="pubmed">19664212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li M, Zhang C, Jin L, et al.  Porphyromonas gingivalis lipopolysaccharide regulates ephrin/Eph signalling in human periodontal ligament fibroblasts[J] J Periodontal Res. 2017;52(5):913–921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5600103</ArticleId>
            <ArticleId IdType="pubmed">28590061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>张 祎.  牙龈卟啉单胞菌脂多糖对成骨细胞—破骨细胞间EphB4-ephrinB2双向传导信号的影响[D] 长春: 吉林大学; 2013. </Citation>
        </Reference>
        <Reference>
          <Citation>Zhang Y.  Effects of lipopolysaccharides from Porphyromonas gingivalis on bidirectional EphB4-ephrinB2 signaling in osteoblasts-osteoclasts[D] Changchun: Jilin University; 2013. </Citation>
        </Reference>
        <Reference>
          <Citation>Gao A, Wang X, Yu H, et al.  Effect of Porphyromonas gingivalis lipopolysaccharide (Pg-LPS) on the expression of EphA2 in osteoblasts and osteoclasts[J] In Vitro Cell Dev Biol Anim. 2016;52(2):228–234.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26559065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>雷 利红, 黄 玫, 吴 燕岷, et al.  EphrinB2/EphB4在牙槽骨吸收-重建过程中的作用[J] 第三军医大学学报. 2013;35(21):2331–2335.</Citation>
        </Reference>
        <Reference>
          <Citation>Lei HL, Huang M, Wu YM, et al.  Role of EphrinB2/EphB4 during alveolar bone resorption and remodeling[J] J Third Milit Med Univ. 2013;35(21):2331–2335.</Citation>
        </Reference>
        <Reference>
          <Citation>Martin TJ, Allan EH, Ho PW, et al.  Communication between ephrinB2 and EphB4 within the osteoblast lineage[J] Adv Exp Med Biol. 2010;658:51–60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19950015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pozniak PD, White MK, Khalili K. TNF-α/NF-κB signaling in the CNS: possible connection to EPHB2[J] J Neuroimmune Pharmacol. 2014;9(2):133–141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3959244</ArticleId>
            <ArticleId IdType="pubmed">24277482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang L, Zhang J, Wang C, et al.  Low concentrations of TNF-α promote osteogenic differentiation via activation of the ephrinB2-EphB4 signalling pathway[J] Cell Prolif. 2017;50(1) doi: 10.1111/cpr.12311.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cpr.12311</ArticleId>
            <ArticleId IdType="pmc">PMC6529098</ArticleId>
            <ArticleId IdType="pubmed">27726217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Einhorn TA. The cell and molecular biology of fracture healing[J] Clin Orthop Relat Res. 1998;355(Suppl):S7–S21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9917622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shen LL, Zhang LX, Wang LM, et al.  Disturbed expression of EphB4, but not EphrinB2, inhibited bone regeneration in an in vivo inflammatory microenvironment[J] Mediators Inflamm. 2016:6430407.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5203910</ArticleId>
            <ArticleId IdType="pubmed">28077917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bletsa A, Berggreen E, Brudvik P. Interleukin-1alpha and tumor necrosis factor-alpha expression during the early phases of orthodontic tooth movement in rats[J] Eur J Oral Sci. 2006;114(5):423–429.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17026509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>AlSwafeeri H, ElKenany W, Mowafy M, et al.  Crevicular alkaline phosphatase activity during the application of two patterns of orthodontic forces[J] J Orthod. 2015;42(1):5–13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25808378</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghijselings E, Coucke W, Verdonck A, et al.  Long-term changes in microbiology and clinical periodontal variables after completion of fixed orthodontic appliances[J] Orthod Craniofac Res. 2014;17(1):49–59.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23992098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sen S, Diercke K, Zingler S, et al.  Compression induces Ephrin-A2 in PDL fibroblasts via c-fos[J] J Dent Res. 2015;94(3):464–472.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4814016</ArticleId>
            <ArticleId IdType="pubmed">25604255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diercke K, Kohl A, Lux CJ, et al.  Strain-dependent up-regulation of ephrin-B2 protein in periodontal ligament fibroblasts contributes to osteogenesis during tooth movement[J] J Biol Chem. 2011;286(43):37651–37664.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3199509</ArticleId>
            <ArticleId IdType="pubmed">21880727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diercke K, Sen S, Kohl A, et al.  Compression-dependent up-regulation of ephrin-A2 in PDL fibroblasts attenuates osteogenesis[J] J Dent Res. 2011;90(9):1108–1115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21724962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>杜 沿林, 张 辉, 孟 蕾, et al.  大鼠正畸牙移动过程中ephrinA2在牙周膜内的表达与分布[J] 牙体牙髓牙周病学杂志. 2016;26(2):74–77, 120.</Citation>
        </Reference>
        <Reference>
          <Citation>Du YL, Zhang H, Meng L, et al.  EphrinA2 expression and distribution in periodontal ligament during orthodontic tooth movement in rats[J] Chin J Conserv Dent. 2016;26(2):74–77, 120.</Citation>
        </Reference>
        <Reference>
          <Citation>Ayman O, Shilpa B, Kellen H, et al.  Ephrin-B2 overexpression predicts for poor prognosis and response to therapy in solid tumors[J] Mol Carcinog. 2017;56(3):1189–1196.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5939940</ArticleId>
            <ArticleId IdType="pubmed">27649287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakada M, Anderson EM, Demuth T, et al.  The phosphorylation of ephrin-B2 ligand promotes glioma cell migrationand invasion[J] Int J Cancer. 2010;126(5):1155–1165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2801764</ArticleId>
            <ArticleId IdType="pubmed">19728339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shao Z, Zhang WF, Chen XM, et al.  Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: correlation with the angiogenesis and clinical outcome[J] Oral Oncol. 2008;44(12):1110–1117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18485799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noguti J, De Moura CF, De Jesus GP, et al.  Metastasis from oral cancer: an overview[J] Cancer Genomics Proteomics. 2012;9(5):329–335.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22990112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eri S, Ayumi T, Riki T, et al.  Ephrin-B2 reverse signaling regulates progression and lymph node metastasis of oral squamous cell carcinoma[J] PLoS One. 2017;12(11):e0188965.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5708812</ArticleId>
            <ArticleId IdType="pubmed">29190834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferguson BD, Tretiakova MS, Lingen MW, et al.  Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies—implications for solid tumors and potential for therapeutic inhibition[J] Growth Factors. 2014;32(6):202–206.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4278660</ArticleId>
            <ArticleId IdType="pubmed">25391996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rutkowski R, Mertens-Walker I, Lisle JE, et al.  Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand[J] Int J Cancer. 2012;131(5):E614–E624.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22161689</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
